Why Doesn’t Regurgitation Improve with Acid Blockers Like Heartburn Does?
Regurgitation responds less well to acid suppression than heartburn does. In a pooled analysis of two randomized controlled trials of potent acid suppression, patients with severe regurgitation symptoms improved at week 4 in 34% (acid taste in the mouth) and 26% (unpleasant upward movement of material from the stomach) of nonerosive reflux disease cases, compared with 49% for high severity substernal burning. In reflux esophagitis, the figures were 44% and 33% for regurgitation versus 55% for substernal burning.
Dr. Kumar’s Take
This research highlights a critical clinical point: not all GERD symptoms respond alike. Acid suppression is aimed squarely at acid, and heartburn is the symptom most directly tied to acid contact with the esophagus. Regurgitation is the physical arrival of stomach contents in the throat or mouth, and blocking acid production does not stop that movement. When a patient tells me their burning is better but material still comes up, I read that as a signal to think about the mechanics of reflux rather than to reach for a higher dose.
What the Research Shows
This was a pooled analysis of data from two randomized controlled trials comparing AZD0865, a potassium-competitive acid blocker, at 25 to 75 mg per day against esomeprazole at 20 to 40 mg per day. One trial enrolled patients with nonerosive reflux disease, the other patients with reflux esophagitis. Entry into both required high severity substernal burning, meaning at least moderate intensity on four or more days in the week before enrollment. Symptoms were characterized with the Reflux Disease Questionnaire, and the response analysis used pooled data from all treatment arms during the fourth week of treatment.
At baseline, 93% of patients with nonerosive reflux disease or reflux esophagitis reported either acid taste in the mouth or unpleasant movement of material upwards from the stomach. Either or both of those symptoms were present and severe in 53% of the nonerosive reflux disease group and 54% of the reflux esophagitis group, and those patients formed the main study outcome. At week 4, response rates for severe regurgitation were significantly lower than for high severity substernal burning in both groups. There were no differences in symptom response between patients with healed and nonhealed reflux esophagitis. The authors concluded that persistent regurgitation is a common cause of incomplete treatment response.
Study Snapshot
Two randomized controlled trials, pooled: 1460 patients with nonerosive reflux disease and 1514 with reflux esophagitis. Treatment arms were AZD0865 25 to 75 mg per day or esomeprazole 20 to 40 mg per day. All patients had high severity substernal burning at entry, defined as at least moderate intensity on four or more days in the preceding week. Regurgitation was characterized by two Reflux Disease Questionnaire items, acid taste in the mouth and unpleasant movement of material upwards from the stomach, and the main outcome was assessed during week 4 of treatment.
Why This Matters for Health and Performance
Understanding the differential response of GERD symptoms has real implications for what patients should expect from treatment. Someone whose burning settles but whose regurgitation persists is not an outlier and is not failing to take the drug correctly. That pattern is what the pooled trial data predict, and it was common enough that the authors named persistent regurgitation as a leading reason treatment response is incomplete.
This matters most at the moment a clinician is deciding what to do next. If regurgitation is the residual symptom, more acid suppression is aimed at the wrong target, and the conversation is better spent on the timing and size of meals, on positioning, and on whether the patient needs a fuller evaluation.
Safety, Limits, and Caveats
Both source trials enrolled patients selected for high severity substernal burning in the week before entry, so the population is not the full spread of people with reflux, and the response figures should be read in that light. Response was measured during the fourth week of treatment, so the results describe short term symptom control rather than long term outcomes.
The findings also rest on patient-reported questionnaire items, which capture the symptom as the patient experiences it rather than an objective measure of reflux events. Both trials tested acid suppression, AZD0865 or esomeprazole, so they speak to how regurgitation responds to acid blockade and not to how it responds to other approaches.
Practical Takeaways
- Recognize that regurgitation and heartburn respond differently to acid suppression despite both being GERD symptoms
- Don’t automatically increase acid suppression if regurgitation persists while heartburn improves
- Expect regurgitation to be common: 93% of patients in these trials had acid taste or upward movement of material at baseline
- Consider approaches aimed at the movement of stomach contents, such as smaller meals, avoiding late eating, and elevating the head of the bed
- Note that in reflux esophagitis, healing status did not change symptom response, so a healed esophagus does not guarantee regurgitation resolves
- Discuss realistic expectations early, since persistent regurgitation on adequate acid suppression is a recognized pattern rather than a treatment failure
Related Studies and Research
- Global Prevalence and Risk Factors of Gastroesophageal Reflux Disease
- The Effects of Modifying Amount and Type of Dietary Carbohydrate on Esophageal Acid Exposure
- Physiology, Pepsin
- Fundic Gland Polyps: Should My Patient Stop Taking PPIs?
- Episode 25: The Great GERD Mistake - How Medicine Made Heartburn Worse and How to Fix It
FAQs
What’s the difference between regurgitation and heartburn in GERD?
Heartburn in this research was measured as substernal burning. Regurgitation was measured as two separate experiences: an acid taste in the mouth, and an unpleasant movement of material upwards from the stomach.
Should I increase my acid blocker dose if regurgitation continues but heartburn improves?
That pattern is exactly what these trials found, and it happened on potent acid suppression. Persistent regurgitation while burning improves is a reason to talk with your doctor about a different approach rather than to assume the dose is too low.
Does healing the esophagus fix regurgitation?
In the reflux esophagitis trial, there were no differences in symptom response between patients with healed and nonhealed esophagitis, so healing alone did not track with better symptom relief.
How common is regurgitation in people with reflux?
At the start of these trials, 93% of patients with nonerosive reflux disease or reflux esophagitis had either acid taste in the mouth or unpleasant movement of material upwards from the stomach. Either or both were present and severe in just over half of each group.
When should I see a specialist for persistent regurgitation?
If regurgitation continues on appropriate acid suppression, or if you develop concerning symptoms like difficulty swallowing, ask for a gastroenterology evaluation.
Bottom Line
Regurgitation responded less well to potent acid suppression than heartburn did in both nonerosive reflux disease and reflux esophagitis. If burning improves but material still comes up, that residual symptom is a recognized cause of incomplete treatment response and calls for a different approach rather than more acid blockade.
